Development of a Multifaceted Ovarian Cancer Therapeutic and Imaging Agent

2009 ◽  
Author(s):  
Francis S. Markland
Keyword(s):  
Ovarian Cancer ◽  
Imaging Agent

Development of a Multifaceted Ovarian Cancer Imaging Agent

2010 ◽  
Author(s):  
Francis S. Markland ◽  
Stephen D. Swenson
Keyword(s):  
Ovarian Cancer ◽  
Cancer Imaging ◽  
Imaging Agent

scholarly journals A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian Cancer

2020 ◽  
Vol 17 (8) ◽  
pp. 3140-3147 ◽  
Author(s):  
Kimberly Fung ◽  
Sai Kiran Sharma ◽  
Outi Keinänen ◽  
Kara Long Roche ◽  
Jason S. Lewis ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Fluorescence Imaging ◽  
Near Infrared ◽  
Imaging Agent ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Near Infrared Fluorescence ◽  
Near Infrared Fluorescence Imaging

scholarly journals Galactosyl Human Serum Albumin-NMP1 Conjugate: A Near Infrared (NIR)-Activatable Fluorescence Imaging Agent to Detect Peritoneal Ovarian Cancer Metastases

2012 ◽  
Vol 23 (8) ◽  
pp. 1671-1679 ◽  
Author(s):  
Vinita M. Alexander ◽  
Kohei Sano ◽  
Zhanqian Yu ◽  
Takahito Nakajima ◽  
Peter L. Choyke ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Human Serum Albumin ◽  
Serum Albumin ◽  
Human Serum ◽  
Fluorescence Imaging ◽  
Near Infrared ◽  
Imaging Agent ◽  
Cancer Metastases ◽  
Galactosyl Human Serum Albumin

scholarly journals A PET imaging agent for evaluating PARP-1 expression in ovarian cancer

2018 ◽  
Vol 128 (5) ◽  
pp. 2116-2126 ◽  
Author(s):  
Mehran Makvandi ◽  
Austin Pantel ◽  
Lauren Schwartz ◽  
Erin Schubert ◽  
Kuiying Xu ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Pet Imaging ◽  
Imaging Agent ◽  
Parp 1

Abstract LB-508: A GSA-NMP1 conjugate: An NIR-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases

2012 ◽  
Author(s):  
Vinita M. Alexander ◽  
Kohei Sano ◽  
Zhanqian Yu ◽  
Takahito Nakajima ◽  
Peter L. Choyke ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Fluorescence Imaging ◽  
Imaging Agent ◽  
Cancer Metastases

Use of 99mTc-EC20 (a folate-targeted imaging agent) to predict response to therapy with EC145 (folate-targeted therapy) in advanced ovarian cancer.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 5034-5034 ◽  
Author(s):  
J. T. Symanowski ◽  
A. H. Maurer ◽  
R. W. Naumann ◽  
N. P. Shah ◽  
D. Morgenstern ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Targeted Therapy ◽  
Advanced Ovarian Cancer ◽  
Response To Therapy ◽  
Imaging Agent ◽  
Targeted Imaging
Sign in / Sign up

Export Citation Format

Share Document